A potential therapeutic effect of catalpol in Duchenne muscular dystrophy revealed by binding with TAK1

scientific article published on 31 August 2020

A potential therapeutic effect of catalpol in Duchenne muscular dystrophy revealed by binding with TAK1 is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/JCSM.12581
P932PMC publication ID7567147
P698PubMed publication ID32869445

P50authorZhenzhou JiangQ90304991
P2093author name stringTao Wang
Chunjie Li
Lei Zhao
Luyong Zhang
Jingwei Jiang
Xiaofei Huang
Lixin Sun
Sijia Li
Xihua Li
Dengqiu Xu
Zeren Sun
P2860cites workDisabled-2 (Dab2) mediates transforming growth factor beta (TGFbeta)-stimulated fibronectin synthesis through TGFbeta-activated kinase 1 and activation of the JNK pathwayQ24302117
Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube sizeQ24314330
Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscleQ24538577
Disruption of TAK1 in hepatocytes causes hepatic injury, inflammation, fibrosis, and carcinogenesisQ33640296
Transforming growth factor-beta-activated kinase 1 is an essential regulator of myogenic differentiationQ33673668
Assessing functional performance in the mdx mouse modelQ34153862
NAD⁺ repletion improves mitochondrial and stem cell function and enhances life span in miceQ34524174
Transforming growth factor-beta1 induces the differentiation of myogenic cells into fibrotic cells in injured skeletal muscle: a key event in muscle fibrogenesisQ35096079
TGF-β1 induced transdifferentiation of rpe cells is mediated by TAK1.Q35596508
TGFβ-activated Kinase 1 (TAK1) Inhibition by 5Z-7-Oxozeaenol Attenuates Early Brain Injury after Experimental Subarachnoid HemorrhageQ35925884
A new therapeutic effect of simvastatin revealed by functional improvement in muscular dystrophyQ36179162
TAK1 modulates satellite stem cell homeostasis and skeletal muscle repairQ36379442
Isolation and culture of individual myofibers and their satellite cells from adult skeletal muscleQ36805017
Sarcolemma-localized nNOS is required to maintain activity after mild exerciseQ36987100
Levels of inflammation and oxidative stress, and a role for taurine in dystropathology of the Golden Retriever Muscular Dystrophy dog model for Duchenne Muscular DystrophyQ37246026
Pathological roles of MAPK signaling pathways in human diseasesQ37676393
Progress toward Gene Therapy for Duchenne Muscular DystrophyQ39246797
Apoptosis signal-regulating kinase 1 is an intracellular inducer of p38 MAPK-mediated myogenic signalling in cardiac myoblasts.Q39550879
Transforming growth factor-beta1 induces transdifferentiation of myoblasts into myofibroblasts via up-regulation of sphingosine kinase-1/S1P3 axis.Q39570413
TGF-β1 activates the canonical NF-κB signaling to promote cell survival and proliferation in dystrophic muscle fibroblasts in vitroQ39999244
Simvastatin offers new prospects for the treatment of Duchenne muscular dystrophyQ40401831
TAK1 inhibition attenuates both inflammation and fibrosis in experimental pneumoconiosisQ40976804
Inhibition of Rho-kinase ameliorates myocardial remodeling and fibrosis in pressure overload and myocardial infarction: role of TGF-β1-TAK1.Q42719528
Inhibiting TGF-β activity improves respiratory function in mdx miceQ42732727
Mitochondrial fusion/fission process involved in the improvement of catalpol on high glucose-induced hepatic mitochondrial dysfunctionQ46705578
Role of transforming growth factor-β in muscle damage and regeneration: focused on eccentric muscle contractionQ49287596
TAK1 regulates skeletal muscle mass and mitochondrial functionQ50130561
Diagnosis and management of Duchenne muscular dystrophy, part 2: respiratory, cardiac, bone health, and orthopaedic managementQ50207377
Interleukin-36α Induces Inflammatory Mediators From Human Pancreatic Myofibroblasts Via a MyD88 Dependent Pathway.Q50947645
TAK1 mediates apoptosis via p38 involve in ischemia-induced renal fibrosis.Q52585204
MiR-499 regulates myoblast proliferation and differentiation by targeting transforming growth factor β receptor 1Q57091417
Catalpol Inhibits Homocysteine-induced Oxidation and Inflammation via Inhibiting Nox4/NF-κB and GRP78/PERK Pathways in Human Aorta Endothelial CellsQ57471151
Mitochondrial dysfunction and inhibition of myoblast differentiation in mice with high-fat-diet-induced pre-diabetesQ58544760
Induced Pluripotent Stem Cells for Duchenne Muscular Dystrophy Modeling and TherapyQ60908818
AAV CRISPR editing rescues cardiac and muscle function for 18 months in dystrophic miceQ60912830
Catalpol prevents denervated muscular atrophy related to the inhibition of autophagy and reduces BAX/BCL2 ratio via mTOR pathwayQ60923753
Inflammation in muscular dystrophy and the beneficial effects of non-steroidal anti-inflammatory drugsQ61919654
A dominant negative TAK1 inhibits cellular fibrotic responses induced by TGF-betaQ73668163
TGF-beta-activated kinase 1 and TAK1-binding protein 1 cooperate to mediate TGF-beta1-induced MKK3-p38 MAPK activation and stimulation of type I collagenQ79771332
MiR-149 suppresses the inflammatory response of chondrocytes in osteoarthritis by down-regulating the activation of TAK1/NF-κBQ88014830
miR-22 regulates C2C12 myoblast proliferation and differentiation by targeting TGFBR1Q88193851
The role of oxymatrine in regulating TGF-β1 in rats with hepatic fibrosisQ88398034
Ethical guidelines for publishing in the Journal of Cachexia, Sarcopenia and Muscle: update 2019Q90985106
A new hypoglycemic mechanism of catalpol revealed by enhancing MyoD/MyoG-mediated myogenesisQ91004843
Possible role of hepatic macrophage recruitment and activation in triptolide-induced hepatotoxicityQ91260077
USP19 Inhibits TNF-α- and IL-1β-Triggered NF-κB Activation by Deubiquitinating TAK1Q92282023
Transforming Growth Factor β-Activated Kinase 1 Regulates Mesenchymal Stem Cell Proliferation Through Stabilization of Yap1/Taz ProteinsQ92954850
Adaptive homeostasis of the vitamin D-vitamin D nuclear receptor axis in 8-methoxypsoralen-induced hepatotoxicityQ93007010
Featured characteristics and pivotal roles of satellite cells in skeletal muscle regenerationQ93173658
P921main subjectDuchenne muscular dystrophyQ1648484
P577publication date2020-08-31
P1433published inJournal of Cachexia, Sarcopenia and MuscleQ6294897
P1476titleA potential therapeutic effect of catalpol in Duchenne muscular dystrophy revealed by binding with TAK1

Reverse relations

Q99557476Catalpol counteracts the pathology in a mouse model of Duchenne muscular dystrophy by inhibiting the TGF-β1/TAK1 signaling pathwaycites workP2860

Search more.